Literature DB >> 8634443

Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy.

F G Blankenberg1, R W Storrs, L Naumovski, T Goralski, D Spielman.   

Abstract

Cells undergoing apoptosis (programmed cell death) display profound morphologic and biochemical changes in the nucleus, cytoplasm, and plasma membrane. We have shown a direct temporal relationship between the onset of apoptosis in Jurkat T-cell lymphoblast cultures and a greater than two-fold increase in the signal intensity of the methylene resonance (at 1.3 ppm) as observed by proton nuclear magnetic resonance spectroscopy (1H NMR). The increase in the methylene resonance intensity was seen when apoptosis was induced by serum deprivation, glucocorticoid, and doxorubicin treatment but not in necrotic (nonapoptotic) cell death. We have found similar changes in a variety of other cell lines undergoing apoptosis including the Hut 78 T-cell leukemia, JY natural killer T-cell leukemia, Daudi B-cell lymphoma, HeLa, and 3T3 fibroblast cell lines. Furthermore, this spectral change was diminished in Bcl-2 overexpressing HL-60 cell cultures treated with doxorubicin, which were relatively resistant to apoptosis, as compared to apoptotic HL-60 cultures. 1H NMR spectroscopy therefore may be useful in detecting apoptotic cell death in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634443

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Applications of magnetic resonance in model systems: cancer therapeutics.

Authors:  J L Evelhoch; R J Gillies; G S Karczmar; J A Koutcher; R J Maxwell; O Nalcioglu; N Raghunand; S M Ronen; B D Ross; H M Swartz
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Taking responsibility for scientific discourse.

Authors:  Seth D Friedman
Journal:  Science       Date:  2008-08-22       Impact factor: 47.728

3.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

Authors:  F G Blankenberg; P D Katsikis; J F Tait; R E Davis; L Naumovski; K Ohtsuki; S Kopiwoda; M J Abrams; M Darkes; R C Robbins; H T Maecker; H W Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Authors:  Y Waerzeggers; R T Ullrich; P Monfared; T Viel; M Weckesser; W Stummer; O Schober; A Winkeler; A H Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 5.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

6.  Comment on "Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain".

Authors:  Seth D Friedman
Journal:  Science       Date:  2008-08-01       Impact factor: 47.728

7.  Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.

Authors:  T M Tsang; J N Haselden; E Holmes
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

8.  Change of choline compounds in sodium selenite-induced apoptosis of rats used as quantitative analysis by in vitro 9.4T MR spectroscopy.

Authors:  Zhen Cao; Lin-Ping Wu; Yun-Xia Li; Yu-Bo Guo; Yao-Wen Chen; Ren-Hua Wu
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

9.  1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles.

Authors:  T Musacchio; M Toniutti; R Kautz; V P Torchilin
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

10.  Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.

Authors:  J Klawitter; N Anderson; J Klawitter; U Christians; D Leibfritz; S G Eckhardt; N J Serkova
Journal:  Br J Cancer       Date:  2009-03-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.